4 news items
Catheter Precision, Inc. (NYSE-American: VTAK) Announces New Chief Commercial Officer
VTAK
1 May 24
heart access in the US. The company's success led to the acquisition by Boston Scientific for $1.75B USD."I am passionate about building
Exploring Emerging Companies with Key Developments Garnering Attention: INBS, INVO, VTAK, RCAT, GCTK
GCTK
INBS
INVO
19 Apr 24
-Invasive 3D Imaging System, in 2024. Targeting a $10 Million Run Rate by Year-End and Access to Top Academic Hospitals, the Company Anticipates
Market Momentum: NASDAQ SmallCaps Sparking Waves in March 2024: CELZ, DYAI, GROM, VTAK, BREA
BREA
CELZ
DIS
8 Mar 24
). In a press release, Creative Medical Technology Holdings announced that it had received FDA authorization for an expanded-access therapy featuring CELZ 201
Stocks Making Waves: Insights into Key Developments and Potential VTAK, TBIO, OCEA, ONMD, KZIA
KZIA
OCEA
ONMD
26 Feb 24
to diversity, organization, and data access in clinical trials. It was disclosed that OneMedNet Corporation interacted with two of its existing customers
- Prev
- 1
- Next